ZYUS Life Sciences Corporation (TSXV:ZYUS)

ZYUS Life Sciences Statistics

Total Valuation

TSXV:ZYUS has a market cap or net worth of CAD 54.70 million. The enterprise value is 67.15 million.

Market Cap	54.70M
Enterprise Value	67.15M

Important Dates

The next estimated earnings date is Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

TSXV:ZYUS has 78.15 million shares outstanding. The number of shares has increased by 5.21% in one year.

Current Share Class	78.15M
Shares Outstanding	78.15M
Shares Change (YoY)	+5.21%
Shares Change (QoQ)	+1.69%
Owned by Insiders (%)	51.63%
Owned by Institutions (%)	0.17%
Float	35.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	113.26
PB Ratio	-5.59
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.97
EV / Sales	139.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.91

Financial Position

The company has a current ratio of 0.13

Current Ratio	0.13
Quick Ratio	0.07
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.34
Interest Coverage	-11.99

Financial Efficiency

Return on equity (ROE) is -1,184.75% and return on invested capital (ROIC) is -66.38%.

Return on Equity (ROE)	-1,184.75%
Return on Assets (ROA)	-40.34%
Return on Invested Capital (ROIC)	-66.38%
Return on Capital Employed (ROCE)	807.20%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	1.11

Taxes

Income Tax	-2.05M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.58% in the last 52 weeks. The beta is 0.84, so TSXV:ZYUS's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-13.58%
50-Day Moving Average	0.68
200-Day Moving Average	0.74
Relative Strength Index (RSI)	54.49
Average Volume (20 Days)	9,700

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSXV:ZYUS had revenue of CAD 483,000 and -34.04 million in losses. Loss per share was -0.46.

Revenue	483,000
Gross Profit	-952,000
Operating Income	-15.35M
Pretax Income	-36.09M
Net Income	-34.04M
EBITDA	-12.93M
EBIT	-15.35M
Loss Per Share	-0.46

Balance Sheet

The company has 559,000 in cash and 13.01 million in debt, giving a net cash position of -12.45 million or -0.16 per share.

Cash & Cash Equivalents	559,000
Total Debt	13.01M
Net Cash	-12.45M
Net Cash Per Share	-0.16
Equity (Book Value)	-9.78M
Book Value Per Share	-0.13
Working Capital	-11.88M

Cash Flow

In the last 12 months, operating cash flow was -9.70 million and capital expenditures -12,000, giving a free cash flow of -9.72 million.

Operating Cash Flow	-9.70M
Capital Expenditures	-12,000
Free Cash Flow	-9.72M
FCF Per Share	-0.12

Margins

Gross Margin	-197.10%
Operating Margin	-3,178.67%
Pretax Margin	-7,472.46%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSXV:ZYUS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.21%
Shareholder Yield	-5.21%
Earnings Yield	-62.22%
FCF Yield	-17.76%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSXV:ZYUS has an Altman Z-Score of -25.43 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-25.43
Piotroski F-Score	3